Companies should weigh the risk of having conflicting remedies for their transactions in different jurisdictions when planning for their deals, the Federal Trade Commission's acting chair said. “The risk of conflicting remedies is the price of doing business,” Rebecca Kelly Slaughter said at a virtual conference.*Slaughter said that while she thinks it’s